Skip to content

Reirradiation of proton vs carbon in patients of high grade glioma: a randomized phase II clinical trial

Reirradiation of proton versus carbon ion in patients of high grade glioma: a randomized phase II clinical trial

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017918
Enrollment
Unknown
Registered
2018-08-21
Start date
2018-10-01
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recurrent high grade glioma

Interventions

arm 1:proton
arm2:carbon

Sponsors

shanghai proton and heavy ion center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. age 18-70 years; 2. pathology confirmed as high grade glioma; 3. tumor recurrent confirmed by imageological or pathology; 4. prior course of standard photon radiotherapy; 5. time interval of over 6 months after primary radiotherapy; 6. no distant and intraspinal metastasis; 7. Written informed consent (must be available before enrollment in the trial.

Exclusion criteria

Exclusion criteria: 1. completely resection of the recurrent glioma; 2. Multifocal Glioma or distant metastatic; 3. prior treatment with interstitial radioactive seeds; 4. Known carcinoma (excluding basal cell carcinoma,squamous cell carcinoma of the skin); 5. Pregnant or lactating women; 6. Patients who have not yet recovered from acute toxicities of prior therapies; 7. Inability of subject to understand character and individual consequences of the clinical trial.

Design outcomes

Primary

MeasureTime frame
overall survival;

Secondary

MeasureTime frame
Progress free survival;side effect;quality of life;

Countries

China

Contacts

Public Contactkong lin

Shanghai Proton and Heavy Ion Center

lin.kong@sphic.org.cn+86 021-38296666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026